Press releases

dots

October 2011


EEB Board of Directors approves regulation to issue shares.

Bogotá, Colombia, 03 October 2011

  • The sale price is COP1.300 per share.
  • Resources will be destined to consolidate the investment plan.

Bogotá, 30 September 2011. The Board of Directors of Empresa de Energía de Bogotá approved last night the regulations to subscribe and place ordinary shares for an initial amount of  $700.000 million. Accordingly, the Company requested the Financial Superintendence authorization to carry out the respective public offer. It consists of 538.461.538 new shares, which value was set at COP1300 each. In the past three months, the average price per share in the market has been COP1.455.

For Mrs. Mónica De Greiff, CEO of Empresa de Energía de Bogotá, the issuance and sale of this share package “is a response to the purpose of consolidating the company's investment plan that it has undertaken in the past year, and which have  led the company to become one of the main economic groups in the country.”

The purpose of Empresa de Energía de Bogotá is that the inhabitants of Bogota and the general public be part of the growing process and generation of dividends of a company with a valuable portfolio of investments in the electricity and natural gas sectors in Colombia and Latin America.  The process also provides the opportunity to current shareholders, employees, pensioned employees, institutional investors and region investors to acquire shares by assignment of compartments or slots specially assigned for them.

In addition to the energy transmission in Colombia, Empresa de Energía de Bogotá participates in the generation business through Emgesa (51,5%) and distribution and commercialization through Codensa (51,5%) and Empresa de Energía de Cundinamarca. In Guatemala is subsidiary to Trecsa executing the most important energy transmission project in this country.  Also, it has a significant participation in ISA in two of its most important transmission projects in Peru.

As regards to natural gas, it has Transportadora de Gas Internacional –TGI, with its pipelines being the most important gas carrier in Colombia. In Peru it is present with Contugas and Cálidda in the natural gas distribution process. Likewise, it participates as shareholder in   Gas Natural/Fenosa and Promigas in Colombia.

During last year, Grupo Energía de Bogotá companies, led by the administrator and headquarters, Empresa de Energía de Bogotá, reached income amounting to COP$2,34 trillion, generating dividends and distributions to its shareholders for more than COP$900 billion in 2011. .

These figures show good management and ability to define investments and operate profitable business in the energy sector in the region. Today, Grupo Energía de Bogotá is a leading corporation in Colombia and Latin America due to its strength, growth and ability to generate dividends to its shareholders. 

About Grupo Energía de Bogotá

Grupo Energía de Bogotá is the leading corporate group in the Colombian energy sector. Through EEB it transports electricity to a market enjoying one of the largest demand in the country and greatest in size, in addition it has control of the largest natural gas carrier in the country, TGI S.A.  In Perú, it company CONTUGAS has a 30 year concession for the transportation and distribution of natural gas in the Ica Department, while CALIDDA is in charge of distributing natural gas in Lima and Callao.. In that same country, ISA, participates in REP S.A. and TRANSMANTARO S.A., which operate 63% of the electricity transmission system in the country. In 2010, it incorporated TRECSA - Transportadora de Centroamérica S.A.- that will build the most important energy infrastructure project in Guatemala and will render electricity transmission services as of 2013.  In addition, it holds a portfolio of significant investments in large companies in the energy sector, amongst which the following stand out CODENSA S.A., EMGESA S.A., GAS NATURAL S.A., Empresa de Energía de Cundinamarca - EEC and Electrificadora del Meta, EMSA and in a lesser scale ISA and ISAGEN.